Combining the power of nature and genomics to create new medicines

The Demuris Portfolio

Programme Hit Lead Lead optimization Candidate Funding / partner
Antibiotics
DC355B1 series. MDR TB
Gram negative antibiotic enhancement
Backup: ~160 Gram negative Hits
Cancer (AML)
DC859A series. FOXO1/3 inhibitor
Mitochondrial proliferation
DC949A series
Antifungals
DC066A. Novel cell wall active compound
Backup: > 600 Hits

Demuris Limited
Newcastle Biomedicine Bio-Incubators,
Faculty of Medical Sciences, Framlington Place,
Newcastle upon Tyne, NE2 4HH, UK

Tel: +44 (0)191 223 5608
Fax: +44 (0)191 223 5609
Email: enquiries@demuris.co.uk

Demuris Limited is registeD7CF33 in England, company number: 06255507

Demuris Limited 2015